Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts

High molecular weight detergent‐insoluble complexes of superoxide dismutase 1 (SOD1) enzyme are a biochemical abnormality associated with mutant SOD1‐linked familial amyotrophic lateral sclerosis (FALS). In the present study, SOD1 protein from spinal cords of transgenic FALS mice was fractionated ac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular biochemistry 2004-04, Vol.91 (5), p.1074-1084
Hauptverfasser: Turner, Bradley J., Lopes, Elizabeth C., Cheema, Surindar S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1084
container_issue 5
container_start_page 1074
container_title Journal of cellular biochemistry
container_volume 91
creator Turner, Bradley J.
Lopes, Elizabeth C.
Cheema, Surindar S.
description High molecular weight detergent‐insoluble complexes of superoxide dismutase 1 (SOD1) enzyme are a biochemical abnormality associated with mutant SOD1‐linked familial amyotrophic lateral sclerosis (FALS). In the present study, SOD1 protein from spinal cords of transgenic FALS mice was fractionated according to solubility in saline, zwitterionic, non‐ionic or anionic detergents. Both endogenous mouse SOD1 and mutant human SOD1 were least soluble in SDS, followed by NP‐40 and CHAPS, with an eight‐fold greater detergent resistance of mutant protein overall. Importantly, high molecular weight mutant SOD1 complexes were isolated with SDS‐extraction only. To reproduce SOD1 aggregate pathology in vitro, primary fibroblasts were isolated and cultured from neonatal transgenic FALS mice. Fibroblasts expressed abundant mutant SOD1 without spontaneous aggregation over time with passage. Proteasomal inhibition of cultures using lactacystin induced dose‐dependent aggregation and increased the SDS‐insoluble fraction of mutant SOD1, but not endogenous SOD1. In contrast, paraquat‐mediated superoxide stress in fibroblasts promoted aggregation of endogenous SOD1, but not mutant SOD1. Treatment of cultures with peroxynitrite or the copper chelator diethyldithiocarbamate (DDC) alone did not modulate aggregation. However, DDC inhibited lactacystin‐induced mutant SOD1 aggregation in transgenic fibroblasts, while exogenous copper slightly augmented aggregation. These data suggest that SOD1 aggregates may derive from proteasomal or oxidation‐mediated oligomerisation pathways from mutant and endogenous subunits respectively. Furthermore, these pathways may be affected by copper availability. We propose that non‐neural cultures such as these transgenic fibroblasts with inducible SOD1 aggregation may be useful for rapid screening of compounds with anti‐aggregation potential in FALS. © 2004 Wiley‐Liss, Inc.
doi_str_mv 10.1002/jcb.10782
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71747110</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71747110</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3612-33d0a90724bbd28fc0aa732071ccbba117b7d8be7cc73af86c4dda87510b50003</originalsourceid><addsrcrecordid>eNp1kE1v1DAQhq0K1C6lh_6ByickDqFjOxsnR1jBtlUpEgLRmzX-yNZbJ9naiej-e1x2C6eeZg7P-2jmJeSUwQcGwM_XRudF1vyAzBg0siirsnxFZiAFFFwwfkTepLQGgKYR_JAcsTmIsinZjKwvezsZr4Ojadq4ODx666j1qZtGTI4yiqtVdCsc_dBT39MxYp9WrveGYrcdxjhs7vIecHQRA00mZEnyiXbDlPOt13HQAdOY3pLXLYbkTvbzmPz88vnH4qK4_ra8XHy8LoyoGC-EsIANSF5qbXndGkCUgoNkxmiNjEktba2dNEYKbOvKlNZiLecM9Dy_KI7Ju513E4eHyaVRdT4ZFwL2Lt-kJJOlZOwJfL8DTb44RdeqTfQdxq1ioJ6KVblY9bfYzJ7tpZPunP1P7pvMwPkO-O2D275sUleLT8_KYpfwaXSP_xIY71UlhZyrXzdLBd9vl_wrq9SF-AOxgZN5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71747110</pqid></control><display><type>article</type><title>Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Turner, Bradley J. ; Lopes, Elizabeth C. ; Cheema, Surindar S.</creator><creatorcontrib>Turner, Bradley J. ; Lopes, Elizabeth C. ; Cheema, Surindar S.</creatorcontrib><description>High molecular weight detergent‐insoluble complexes of superoxide dismutase 1 (SOD1) enzyme are a biochemical abnormality associated with mutant SOD1‐linked familial amyotrophic lateral sclerosis (FALS). In the present study, SOD1 protein from spinal cords of transgenic FALS mice was fractionated according to solubility in saline, zwitterionic, non‐ionic or anionic detergents. Both endogenous mouse SOD1 and mutant human SOD1 were least soluble in SDS, followed by NP‐40 and CHAPS, with an eight‐fold greater detergent resistance of mutant protein overall. Importantly, high molecular weight mutant SOD1 complexes were isolated with SDS‐extraction only. To reproduce SOD1 aggregate pathology in vitro, primary fibroblasts were isolated and cultured from neonatal transgenic FALS mice. Fibroblasts expressed abundant mutant SOD1 without spontaneous aggregation over time with passage. Proteasomal inhibition of cultures using lactacystin induced dose‐dependent aggregation and increased the SDS‐insoluble fraction of mutant SOD1, but not endogenous SOD1. In contrast, paraquat‐mediated superoxide stress in fibroblasts promoted aggregation of endogenous SOD1, but not mutant SOD1. Treatment of cultures with peroxynitrite or the copper chelator diethyldithiocarbamate (DDC) alone did not modulate aggregation. However, DDC inhibited lactacystin‐induced mutant SOD1 aggregation in transgenic fibroblasts, while exogenous copper slightly augmented aggregation. These data suggest that SOD1 aggregates may derive from proteasomal or oxidation‐mediated oligomerisation pathways from mutant and endogenous subunits respectively. Furthermore, these pathways may be affected by copper availability. We propose that non‐neural cultures such as these transgenic fibroblasts with inducible SOD1 aggregation may be useful for rapid screening of compounds with anti‐aggregation potential in FALS. © 2004 Wiley‐Liss, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.10782</identifier><identifier>PMID: 15034941</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Acetylcysteine - analogs &amp; derivatives ; Acetylcysteine - pharmacology ; aggregation ; amyotrophic lateral sclerosis ; Amyotrophic Lateral Sclerosis - enzymology ; Amyotrophic Lateral Sclerosis - genetics ; Amyotrophic Lateral Sclerosis - metabolism ; Animals ; Animals, Newborn ; Blotting, Western ; Cell Survival - drug effects ; Cell Survival - genetics ; Chelating Agents - pharmacology ; Chlorides - pharmacology ; Copper - metabolism ; Copper - pharmacology ; DDC ; Detergents - chemistry ; Disease Models, Animal ; Ditiocarb - pharmacology ; fibroblasts ; Fibroblasts - cytology ; Fibroblasts - drug effects ; Fibroblasts - metabolism ; Humans ; Immunohistochemistry ; Mice ; Mice, Transgenic ; Minocycline - pharmacology ; Mutation - genetics ; oxidant stress ; Oxidative Stress ; Paraquat - pharmacology ; Peroxynitrous Acid - pharmacology ; proteasome ; Proteasome Endopeptidase Complex - metabolism ; Proteasome Inhibitors ; Protein Binding - drug effects ; SOD1 ; Solubility ; Spinal Cord - chemistry ; Superoxide Dismutase - chemistry ; Superoxide Dismutase - genetics ; Superoxide Dismutase - metabolism ; Superoxide Dismutase-1 ; Zinc Compounds - pharmacology</subject><ispartof>Journal of cellular biochemistry, 2004-04, Vol.91 (5), p.1074-1084</ispartof><rights>Copyright © 2004 Wiley‐Liss, Inc.</rights><rights>Copyright 2004 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3612-33d0a90724bbd28fc0aa732071ccbba117b7d8be7cc73af86c4dda87510b50003</citedby><cites>FETCH-LOGICAL-c3612-33d0a90724bbd28fc0aa732071ccbba117b7d8be7cc73af86c4dda87510b50003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcb.10782$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcb.10782$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15034941$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Turner, Bradley J.</creatorcontrib><creatorcontrib>Lopes, Elizabeth C.</creatorcontrib><creatorcontrib>Cheema, Surindar S.</creatorcontrib><title>Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>High molecular weight detergent‐insoluble complexes of superoxide dismutase 1 (SOD1) enzyme are a biochemical abnormality associated with mutant SOD1‐linked familial amyotrophic lateral sclerosis (FALS). In the present study, SOD1 protein from spinal cords of transgenic FALS mice was fractionated according to solubility in saline, zwitterionic, non‐ionic or anionic detergents. Both endogenous mouse SOD1 and mutant human SOD1 were least soluble in SDS, followed by NP‐40 and CHAPS, with an eight‐fold greater detergent resistance of mutant protein overall. Importantly, high molecular weight mutant SOD1 complexes were isolated with SDS‐extraction only. To reproduce SOD1 aggregate pathology in vitro, primary fibroblasts were isolated and cultured from neonatal transgenic FALS mice. Fibroblasts expressed abundant mutant SOD1 without spontaneous aggregation over time with passage. Proteasomal inhibition of cultures using lactacystin induced dose‐dependent aggregation and increased the SDS‐insoluble fraction of mutant SOD1, but not endogenous SOD1. In contrast, paraquat‐mediated superoxide stress in fibroblasts promoted aggregation of endogenous SOD1, but not mutant SOD1. Treatment of cultures with peroxynitrite or the copper chelator diethyldithiocarbamate (DDC) alone did not modulate aggregation. However, DDC inhibited lactacystin‐induced mutant SOD1 aggregation in transgenic fibroblasts, while exogenous copper slightly augmented aggregation. These data suggest that SOD1 aggregates may derive from proteasomal or oxidation‐mediated oligomerisation pathways from mutant and endogenous subunits respectively. Furthermore, these pathways may be affected by copper availability. We propose that non‐neural cultures such as these transgenic fibroblasts with inducible SOD1 aggregation may be useful for rapid screening of compounds with anti‐aggregation potential in FALS. © 2004 Wiley‐Liss, Inc.</description><subject>Acetylcysteine - analogs &amp; derivatives</subject><subject>Acetylcysteine - pharmacology</subject><subject>aggregation</subject><subject>amyotrophic lateral sclerosis</subject><subject>Amyotrophic Lateral Sclerosis - enzymology</subject><subject>Amyotrophic Lateral Sclerosis - genetics</subject><subject>Amyotrophic Lateral Sclerosis - metabolism</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Blotting, Western</subject><subject>Cell Survival - drug effects</subject><subject>Cell Survival - genetics</subject><subject>Chelating Agents - pharmacology</subject><subject>Chlorides - pharmacology</subject><subject>Copper - metabolism</subject><subject>Copper - pharmacology</subject><subject>DDC</subject><subject>Detergents - chemistry</subject><subject>Disease Models, Animal</subject><subject>Ditiocarb - pharmacology</subject><subject>fibroblasts</subject><subject>Fibroblasts - cytology</subject><subject>Fibroblasts - drug effects</subject><subject>Fibroblasts - metabolism</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Minocycline - pharmacology</subject><subject>Mutation - genetics</subject><subject>oxidant stress</subject><subject>Oxidative Stress</subject><subject>Paraquat - pharmacology</subject><subject>Peroxynitrous Acid - pharmacology</subject><subject>proteasome</subject><subject>Proteasome Endopeptidase Complex - metabolism</subject><subject>Proteasome Inhibitors</subject><subject>Protein Binding - drug effects</subject><subject>SOD1</subject><subject>Solubility</subject><subject>Spinal Cord - chemistry</subject><subject>Superoxide Dismutase - chemistry</subject><subject>Superoxide Dismutase - genetics</subject><subject>Superoxide Dismutase - metabolism</subject><subject>Superoxide Dismutase-1</subject><subject>Zinc Compounds - pharmacology</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1v1DAQhq0K1C6lh_6ByickDqFjOxsnR1jBtlUpEgLRmzX-yNZbJ9naiej-e1x2C6eeZg7P-2jmJeSUwQcGwM_XRudF1vyAzBg0siirsnxFZiAFFFwwfkTepLQGgKYR_JAcsTmIsinZjKwvezsZr4Ojadq4ODx666j1qZtGTI4yiqtVdCsc_dBT39MxYp9WrveGYrcdxjhs7vIecHQRA00mZEnyiXbDlPOt13HQAdOY3pLXLYbkTvbzmPz88vnH4qK4_ra8XHy8LoyoGC-EsIANSF5qbXndGkCUgoNkxmiNjEktba2dNEYKbOvKlNZiLecM9Dy_KI7Ju513E4eHyaVRdT4ZFwL2Lt-kJJOlZOwJfL8DTb44RdeqTfQdxq1ioJ6KVblY9bfYzJ7tpZPunP1P7pvMwPkO-O2D275sUleLT8_KYpfwaXSP_xIY71UlhZyrXzdLBd9vl_wrq9SF-AOxgZN5</recordid><startdate>20040401</startdate><enddate>20040401</enddate><creator>Turner, Bradley J.</creator><creator>Lopes, Elizabeth C.</creator><creator>Cheema, Surindar S.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040401</creationdate><title>Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts</title><author>Turner, Bradley J. ; Lopes, Elizabeth C. ; Cheema, Surindar S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3612-33d0a90724bbd28fc0aa732071ccbba117b7d8be7cc73af86c4dda87510b50003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Acetylcysteine - analogs &amp; derivatives</topic><topic>Acetylcysteine - pharmacology</topic><topic>aggregation</topic><topic>amyotrophic lateral sclerosis</topic><topic>Amyotrophic Lateral Sclerosis - enzymology</topic><topic>Amyotrophic Lateral Sclerosis - genetics</topic><topic>Amyotrophic Lateral Sclerosis - metabolism</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Blotting, Western</topic><topic>Cell Survival - drug effects</topic><topic>Cell Survival - genetics</topic><topic>Chelating Agents - pharmacology</topic><topic>Chlorides - pharmacology</topic><topic>Copper - metabolism</topic><topic>Copper - pharmacology</topic><topic>DDC</topic><topic>Detergents - chemistry</topic><topic>Disease Models, Animal</topic><topic>Ditiocarb - pharmacology</topic><topic>fibroblasts</topic><topic>Fibroblasts - cytology</topic><topic>Fibroblasts - drug effects</topic><topic>Fibroblasts - metabolism</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Minocycline - pharmacology</topic><topic>Mutation - genetics</topic><topic>oxidant stress</topic><topic>Oxidative Stress</topic><topic>Paraquat - pharmacology</topic><topic>Peroxynitrous Acid - pharmacology</topic><topic>proteasome</topic><topic>Proteasome Endopeptidase Complex - metabolism</topic><topic>Proteasome Inhibitors</topic><topic>Protein Binding - drug effects</topic><topic>SOD1</topic><topic>Solubility</topic><topic>Spinal Cord - chemistry</topic><topic>Superoxide Dismutase - chemistry</topic><topic>Superoxide Dismutase - genetics</topic><topic>Superoxide Dismutase - metabolism</topic><topic>Superoxide Dismutase-1</topic><topic>Zinc Compounds - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Turner, Bradley J.</creatorcontrib><creatorcontrib>Lopes, Elizabeth C.</creatorcontrib><creatorcontrib>Cheema, Surindar S.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Turner, Bradley J.</au><au>Lopes, Elizabeth C.</au><au>Cheema, Surindar S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2004-04-01</date><risdate>2004</risdate><volume>91</volume><issue>5</issue><spage>1074</spage><epage>1084</epage><pages>1074-1084</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>High molecular weight detergent‐insoluble complexes of superoxide dismutase 1 (SOD1) enzyme are a biochemical abnormality associated with mutant SOD1‐linked familial amyotrophic lateral sclerosis (FALS). In the present study, SOD1 protein from spinal cords of transgenic FALS mice was fractionated according to solubility in saline, zwitterionic, non‐ionic or anionic detergents. Both endogenous mouse SOD1 and mutant human SOD1 were least soluble in SDS, followed by NP‐40 and CHAPS, with an eight‐fold greater detergent resistance of mutant protein overall. Importantly, high molecular weight mutant SOD1 complexes were isolated with SDS‐extraction only. To reproduce SOD1 aggregate pathology in vitro, primary fibroblasts were isolated and cultured from neonatal transgenic FALS mice. Fibroblasts expressed abundant mutant SOD1 without spontaneous aggregation over time with passage. Proteasomal inhibition of cultures using lactacystin induced dose‐dependent aggregation and increased the SDS‐insoluble fraction of mutant SOD1, but not endogenous SOD1. In contrast, paraquat‐mediated superoxide stress in fibroblasts promoted aggregation of endogenous SOD1, but not mutant SOD1. Treatment of cultures with peroxynitrite or the copper chelator diethyldithiocarbamate (DDC) alone did not modulate aggregation. However, DDC inhibited lactacystin‐induced mutant SOD1 aggregation in transgenic fibroblasts, while exogenous copper slightly augmented aggregation. These data suggest that SOD1 aggregates may derive from proteasomal or oxidation‐mediated oligomerisation pathways from mutant and endogenous subunits respectively. Furthermore, these pathways may be affected by copper availability. We propose that non‐neural cultures such as these transgenic fibroblasts with inducible SOD1 aggregation may be useful for rapid screening of compounds with anti‐aggregation potential in FALS. © 2004 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15034941</pmid><doi>10.1002/jcb.10782</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0730-2312
ispartof Journal of cellular biochemistry, 2004-04, Vol.91 (5), p.1074-1084
issn 0730-2312
1097-4644
language eng
recordid cdi_proquest_miscellaneous_71747110
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Acetylcysteine - analogs & derivatives
Acetylcysteine - pharmacology
aggregation
amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis - enzymology
Amyotrophic Lateral Sclerosis - genetics
Amyotrophic Lateral Sclerosis - metabolism
Animals
Animals, Newborn
Blotting, Western
Cell Survival - drug effects
Cell Survival - genetics
Chelating Agents - pharmacology
Chlorides - pharmacology
Copper - metabolism
Copper - pharmacology
DDC
Detergents - chemistry
Disease Models, Animal
Ditiocarb - pharmacology
fibroblasts
Fibroblasts - cytology
Fibroblasts - drug effects
Fibroblasts - metabolism
Humans
Immunohistochemistry
Mice
Mice, Transgenic
Minocycline - pharmacology
Mutation - genetics
oxidant stress
Oxidative Stress
Paraquat - pharmacology
Peroxynitrous Acid - pharmacology
proteasome
Proteasome Endopeptidase Complex - metabolism
Proteasome Inhibitors
Protein Binding - drug effects
SOD1
Solubility
Spinal Cord - chemistry
Superoxide Dismutase - chemistry
Superoxide Dismutase - genetics
Superoxide Dismutase - metabolism
Superoxide Dismutase-1
Zinc Compounds - pharmacology
title Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T22%3A24%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inducible%20superoxide%20dismutase%201%20aggregation%20in%20transgenic%20amyotrophic%20lateral%20sclerosis%20mouse%20fibroblasts&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Turner,%20Bradley%20J.&rft.date=2004-04-01&rft.volume=91&rft.issue=5&rft.spage=1074&rft.epage=1084&rft.pages=1074-1084&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.10782&rft_dat=%3Cproquest_cross%3E71747110%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71747110&rft_id=info:pmid/15034941&rfr_iscdi=true